Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine Plus Lithium in Treatment-Resistant Depression
NCT01880593Phase 2Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jul 2013
- Primary completion
- Nov 2016
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lithium in treatment-resistant depression (TRD), sponsored by Icahn School of Medicine at Mount Sinai. Started Jul 2013; status: completed.
02
Drugs
lithium
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT01880593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01880593.